Compounds and compositions as protein kinase inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/02 (2006.01) A61K 31/519 (2006.01) A61P 29/00 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2626350

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the AbI, Bcr-Abl, Aurora- A, AxI, BMX, CHK2, c-RAF, cSRC, Fes, FGFR3, Flt3, IKK.alpha., IR, JNK2.alpha.2, Lck, Met, MKK6, MST2, p70S6K, PDGFR.alpha., PKA, PKD2, ROCK-II, Ros, Rskl, SAPK2.alpha., SAPK2.beta., SAPK3 SAPK4, Syk, Tie2 and TrkB kinases.

L'invention concerne une nouvelle classe de composés, des compositions pharmaceutiques qui comprennent ces composés et des procédés d'utilisation de ces composés pour traiter ou prévenir des maladies ou des affections associés à une activité anormale ou dérégulée des kinases et en particulier les maladies ou affections associés à une activation anormale des kinases d'AbI, de Bcr-Abl, d'Aurora-A, d'AxI, de BMX, de CHK2, de c-RAF, de cSRC, de Fes, de FGFR3, de Flt3, d'IKK.alpha., d'IR, de JNK2.alpha.2, de Lck, de Met, de MKK6, de MST2, de p70S6K, de PDGFR.alpha., de PKA, de PKD2, de ROCK-II, de Ros, de Rskl, de SAPK2.alpha., de SAPK2.beta., de SAPK3, de SAPK4, de Syk, de Tie2 et de TrkB.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Compounds and compositions as protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds and compositions as protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and compositions as protein kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1667988

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.